M.G. Rowlands

821 total citations
30 papers, 676 citations indexed

About

M.G. Rowlands is a scholar working on Genetics, Molecular Biology and Organic Chemistry. According to data from OpenAlex, M.G. Rowlands has authored 30 papers receiving a total of 676 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Genetics, 11 papers in Molecular Biology and 5 papers in Organic Chemistry. Recurrent topics in M.G. Rowlands's work include Estrogen and related hormone effects (18 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Analytical Chemistry and Chromatography (3 papers). M.G. Rowlands is often cited by papers focused on Estrogen and related hormone effects (18 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Analytical Chemistry and Chromatography (3 papers). M.G. Rowlands collaborates with scholars based in United Kingdom, United States and France. M.G. Rowlands's co-authors include Michael Jarman, Grace K. Poon, Mitch Dowsett, R. Charles Coombes, Rachel Grimshaw, Matthew Law, Roger Hewson, Rumina Hasan, John W. Chamberlain and Kevin R. Bewley and has published in prestigious journals such as Analytical Biochemistry, Oncogene and FEBS Letters.

In The Last Decade

M.G. Rowlands

29 papers receiving 647 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.G. Rowlands United Kingdom 16 306 294 169 115 90 30 676
V. Wiebe United States 7 369 1.2× 193 0.7× 209 1.2× 98 0.9× 15 0.2× 15 536
Bruce Dickstein United States 14 122 0.4× 327 1.1× 573 3.4× 80 0.7× 39 0.4× 20 949
Akihiro Tasaka Japan 16 115 0.4× 204 0.7× 54 0.3× 87 0.8× 17 0.2× 29 744
Sotiria Boukouvala Greece 19 114 0.4× 646 2.2× 257 1.5× 240 2.1× 24 0.3× 32 1.1k
Tomáš Smutný Czechia 17 86 0.3× 224 0.8× 162 1.0× 219 1.9× 24 0.3× 33 710
Shankar M. Singh Canada 16 227 0.7× 314 1.1× 52 0.3× 33 0.3× 13 0.1× 33 826
Wen Yan United States 14 77 0.3× 316 1.1× 53 0.3× 47 0.4× 64 0.7× 19 658
Bernard Nutley United Kingdom 13 58 0.2× 268 0.9× 160 0.9× 38 0.3× 23 0.3× 18 718
Indra Dwivedy India 5 451 1.5× 431 1.5× 147 0.9× 111 1.0× 18 0.2× 14 790

Countries citing papers authored by M.G. Rowlands

Since Specialization
Citations

This map shows the geographic impact of M.G. Rowlands's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.G. Rowlands with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.G. Rowlands more than expected).

Fields of papers citing papers by M.G. Rowlands

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.G. Rowlands. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.G. Rowlands. The network helps show where M.G. Rowlands may publish in the future.

Co-authorship network of co-authors of M.G. Rowlands

This figure shows the co-authorship network connecting the top 25 collaborators of M.G. Rowlands. A scholar is included among the top collaborators of M.G. Rowlands based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.G. Rowlands. M.G. Rowlands is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rayter, Sydonia, Richard Elliott, Jon Travers, et al.. (2007). A chemical inhibitor of PPM1D that selectively kills cells overexpressing PPM1D. Oncogene. 27(8). 1036–1044. 66 indexed citations
2.
Garrett, Michelle D., John Caldwell, M.G. Rowlands, et al.. (2004). 322 Novel isoquinoline-5-sulfonamides as biochemical and cellular inhibitors of PKB/AKt. European Journal of Cancer Supplements. 2(8). 98–98. 3 indexed citations
3.
Hardcastle, Anthea, M.G. Rowlands, Yvette Newbatt, et al.. (2001). High-Throughput Screening for Identification of Small Molecule Inhibitors of Histone Acetyltransferases Using Scintillating Microplates (FlashPlate). Analytical Biochemistry. 298(1). 62–68. 38 indexed citations
4.
Dowsett, Mitch, et al.. (1998). Comparison of biochemical aromatase activity with aromatase immunhistochemistry in human breast carcinomas. Breast Cancer Research and Treatment. 49(S1). S101–S107. 34 indexed citations
5.
Hardcastle, Ian R., M.G. Rowlands, & Michael Jarman. (1996). Antiestrogens as calmodulin antagonists. Current Medicinal Chemistry. 3(3). 211–226. 6 indexed citations
6.
Bretti, S., Maria Gilleece, M.G. Rowlands, et al.. (1996). An open phase I study to assess the biological effects of a continuous intravenous infusion of interleukin-3 followed by granulocyte macrophage-colony stimulating factor. European Journal of Cancer. 32(7). 1171–1178. 4 indexed citations
7.
Dowsett, Mitch, et al.. (1996). The control and biological importance of intratumoural aromatase in breast cancer. The Journal of Steroid Biochemistry and Molecular Biology. 56(1-6). 145–150. 25 indexed citations
8.
Poon, Grace K., David M. Vigushin, Leslie J. Griggs, et al.. (1996). IDENTIFICATION AND CHARACTERIZATION OF LIMONENE METABOLITES IN PATIENTS WITH ADVANCED CANCER BY LIQUID CHROMATOGRAPHY/MASS SPECTROMETRY. Drug Metabolism and Disposition. 24(5). 565–571. 39 indexed citations
9.
Hardcastle, Ian R., et al.. (1996). Homologs of Idoxifene:  Variation of Estrogen Receptor Binding and Calmodulin Antagonism with Chain Length. Journal of Medicinal Chemistry. 39(4). 999–1004. 18 indexed citations
10.
Bates, Paula J., Michael J. McLean, M.G. Rowlands, et al.. (1995). Inhibition of aromatase expression by a psoralen‐linked triplex‐forming oligonucleotide targeted to a coding sequence. FEBS Letters. 372(2-3). 222–228. 18 indexed citations
11.
Macaulay, Valentine M., et al.. (1994). Biological effects of stable overexpression of aromatase in human hormone-dependent breast cancer cells. British Journal of Cancer. 69(1). 77–83. 29 indexed citations
12.
Rowlands, M.G., et al.. (1994). Intratumoral oestrone sulphatase activity as a prognostic marker in human breast carcinoma. British Journal of Cancer. 69(3). 555–561. 51 indexed citations
13.
Coombes, R. Charles, Michael Jarman, Mitch Dowsett, et al.. (1993). New Endocrine Agents for the Treatment of Breast Cancer. Recent results in cancer research. 127. 267–275. 3 indexed citations
14.
Chander, Surinder K., et al.. (1992). Oestrone sulphatase activity in mammary tumours and the liver of N-nitrosomethylurea treated rats. British Journal of Cancer. 65(1). 72–76. 3 indexed citations
15.
Poon, Grace K., Michael Jarman, M.G. Rowlands, et al.. (1992). Investigation of conjugated metabolites of 4-hydroxyandrost-4-ene-3,17-dione in patient urine by liquid chromatography-atmospheric pressure ionization mass spectrometry.. Drug Metabolism and Disposition. 20(6). 941–947. 11 indexed citations
16.
Poon, Grace K., et al.. (1991). Determination of 4-hydroxyandrost-4-ene-3,17-dione metabolism in breast cancer patients using high-performance liquid chromatography—mass spectrometry. Journal of Chromatography B Biomedical Sciences and Applications. 565(1-2). 75–88. 25 indexed citations
17.
Barrie, S. Elaine, M.G. Rowlands, A. B. Foster, & Michael Jarman. (1989). Inhibition of 17α-hydroxylase/C17-C20 lyase by bifluranol and its analogues. Journal of Steroid Biochemistry. 33(6). 1191–1195. 15 indexed citations
18.
Smith, H J, et al.. (1988). Structure-Activity Relationships for Non-Steroidal Inhibitors of Aromatase. Journal of enzyme inhibition. 2(3). 215–229. 29 indexed citations
19.
Jarman, Michael, et al.. (1988). Selective inhibition of cholesterol side-chain cleavage by potential pro-drug forms of aminoglutethimide.. PubMed. 3(3). 185–90. 6 indexed citations
20.
Foster, A., Leslie J. Griggs, Ian Howe, et al.. (1984). Metabolism of aminoglutethimide in humans. Identification of four new urinary metabolites.. Drug Metabolism and Disposition. 12(4). 511–516. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026